.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Daiichi Sankyo
Chubb
Deloitte
Baxter
Merck
US Army
Medtronic
Cerilliant

Generated: July 23, 2017

DrugPatentWatch Database Preview

Orphenadrine citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for orphenadrine citrate and what is the scope of orphenadrine citrate freedom to operate?

Orphenadrine citrate
is the generic ingredient in two branded drugs marketed by Watson Labs, Sandoz, Tedor Pharma Inc, Teligent, Medicis, Invagen Pharms, West-ward Pharms Int, Ascot, Impax Pharms, Akorn, Gavis Pharms, and Sagent Pharms, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for orphenadrine citrate. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: orphenadrine citrate

Tradenames:2
Patents:1
Applicants:12
NDAs:15
Drug Master File Entries: see list9
Suppliers / Packagers: see list28
Clinical Trials: see list522
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:orphenadrine citrate at DailyMed

Pharmacology for Ingredient: orphenadrine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
ORPHENADRINE CITRATE
orphenadrine citrate
INJECTABLE;INJECTION040484-001May 24, 2006APRXNoYes► Subscribe► Subscribe
Invagen Pharms
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL091158-001Jul 27, 2012ABRXNoNo► Subscribe► Subscribe
Teligent
NORFLEX
orphenadrine citrate
INJECTABLE;INJECTION013055-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Tedor Pharma Inc
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL040249-001Jan 29, 1999ABRXNoNo► Subscribe► Subscribe
Sagent Pharms
ORPHENADRINE CITRATE
orphenadrine citrate
INJECTABLE;INJECTION090585-001Aug 30, 2011APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Teva
Farmers Insurance
Deloitte
Express Scripts
Accenture
Julphar
Moodys
US Army
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot